This is a demo store. No orders will be fulfilled.

Casirivimab (anti-Spike RBD) - Primary antibody, specific to Spike RBD, >95% (SDS-PAGE&SEC); Endotoxin Level, INHIBITOR of Spike glycoprotein inhibitor

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: SARS-CoV-2
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab182896
Grouped product items
SKU Size
Availability
Price Qty
Ab182896-100μg
100μg
10
$99.90
Ab182896-1mg
1mg
4
$489.90
Ab182896-5mg
5mg
1
$1,279.90
Ab182896-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,049.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Casirivimab (anti-Spike RBD) - Primary antibody, specific to Spike RBD, >95% (SDS-PAGE&SEC); Endotoxin Level
Synonyms Spike RBD antibody | Anti-Spike RBD antibody | Anti-Human Spike RBD Recombinant Antibody | Anti-Spike RBD Reference Antibody | SARS-CoV-2 antibody | Anti-SARS-CoV-2 antibody | REGN10933 | Spike RBD antibody | Anti-Spike RBD antibody | Anti-Human Spike RBD
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity Spike RBD
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type INHIBITOR
Mechanism of action INHIBITOR of Spike glycoprotein inhibitor
Product Description

Casirivimab (anti-Spike RBD) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Casirivimab (anti-Spike RBD) lacks efficacy against COVID-19 variants. Casirivimab (anti-Spike RBD) can be used in combination with Imdevimab, it reduces viral load and improves diseases.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

Isotype Human IgG1
Light Chain Type kappa
SDS-PAGE 26.3 kDa (Light Chain) & 51.5 kDa (Heavy Chain), under reducing conditions; 199.6 kDa, under non-reducing conditions.
Purification Method Protein A purified
Purity >95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 2415933-42-3

Images

Casirivimab (anti-Spike RBD) (Ab182896) - ELISA
Immobilized Human Spike RBD protein ( rp155929) at 1.0 μg/mL can bind Casirivimab (anti-Spike RBD) (Ab182896) with the EC50 of 10.50 ng/mL.

Casirivimab (anti-Spike RBD) (Ab182896) - SEC
The purity of Casirivimab (anti-Spike RBD) (Ab182896) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
ZJ24F0505630 Certificate of Analysis May 15, 2024 Ab182896
ZJ24F0505629 Certificate of Analysis May 15, 2024 Ab182896
ZJ24F0505628 Certificate of Analysis May 15, 2024 Ab182896

Alternative Products

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.